FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Symptoms patents



      
           
This page is updated frequently with new Symptoms-related patent applications. Subscribe to the Symptoms RSS feed to automatically get the update: related Symptoms RSS feeds. RSS updates for this page: Symptoms RSS RSS


Devices and methods for tissue immobilization and non-invasive lower urinary tract analysis

Devices and methods for tissue immobilization and non-invasive lower urinary tract analysis

Date/App# patent app List of recent Symptoms-related patents
09/25/14
20140288063
 Heterocyclic substituted pyrimidine compound patent thumbnailHeterocyclic substituted pyrimidine compound
The present invention pertains to the field of medical technology, and particularly relates to a heterocyclic substituted pyrimidine compound represented by general formula (i) and its pharmaceutically acceptable salt thereof, wherein r1, r2, r3, r4 and r5 are as defined in the description, the present invention also relates to a preparation method of the compound, a pharmaceutical composition containing the compound, and a use of the compound and the pharmaceutical composition in preparation of a medicine for enhancing a cgmp signal transduction function or a medicine for treating or preventing sexual dysfunction and diseases with lower urinary tract symptoms.. .
09/18/14
20140275839
 Devices and methods for tissue immobilization and non-invasive lower urinary tract analysis patent thumbnailDevices and methods for tissue immobilization and non-invasive lower urinary tract analysis
Provided are devices and methods suitable for immobilizing tissue and for use in non-invasive methods of assessing lower urinary tract symptoms as well as in surgical application.. .
09/11/14
20140256756
 Piperidinyl-substituted lactams as gpr119 modulators patent thumbnailPiperidinyl-substituted lactams as gpr119 modulators
Compounds of formula (i) and pharmaceutically acceptable salts thereof in which x1, x2, x3, l, r3, r4, r5, r7 and n have the meanings given in the specification, are modulators of gpr119 and are useful in the treatment or prevention of diseases such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.. .
08/14/14
20140228362
 Method of treatment or prophylaxis patent thumbnailMethod of treatment or prophylaxis
The present invention is directed to methods and agents that are useful in the prevention and amelioration of signs and symptoms associated with neuropathic conditions. More particularly, the present invention discloses the use of angiotensin ii receptor 2 (at2 receptor) antagonists for the treatment, prophylaxis, reversal and/or symptomatic relief of neuropathic pain, including mechanical hyperalgesia, thermal or mechanical allodynia, diabetic pain and entrapment pain, in vertebrate animals and particularly in human subjects.
04/24/14
20140114678
 Secure delivery of personalized neuromodulation treatment protocols across the internet to a stimulator device patent thumbnailSecure delivery of personalized neuromodulation treatment protocols across the internet to a stimulator device
This invention manages the variation of neuromodulation sequences inherent in effective treatment for poly-substance abuse and dependence through downloadable neuromodulation protocols for common poly-substance combinations. The substance abuse profiles and the poly-substance neuromodulation protocols are placed on an internet connected server, allowing effective management of complex treatments via network-attached client software to addiction clinics in most of the geographic areas in the world.
04/24/14
20140113970
 Dispensing system patent thumbnailDispensing system
The invention provides systems and methods for controlled dispensing of topical analgesics contained in a metered dispensing system. The systems and method are useful for treating signs and symptoms of osteoarthritis.
04/10/14
20140100241
 Drug detoxification protocol using microdosing patent thumbnailDrug detoxification protocol using microdosing
This invention relates to use of an opioid receptor agonist in microdose quantities to reduce or eliminate the withdrawal symptoms associated with discontinuing drug use. The dosage of the agonist is reduced over an extended period of time..
01/16/14
20140017177
 Silene capensis for inhibiting cravings patent thumbnailSilene capensis for inhibiting cravings
A composition can include: silene extract; and a carrier having the silene extract. The composition can include an active agent, such as a pharmaceutical or a nutraceutical.
12/26/13
20130345313
 Method for the treatment or prevention of lower urinary tract symptoms patent thumbnailMethod for the treatment or prevention of lower urinary tract symptoms
This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.. .
12/19/13
20130338116
 Compounds and methods for the treatment of pain and other diseases patent thumbnailCompounds and methods for the treatment of pain and other diseases
The present invention relates generally to pharmaceutical agents, and in particular, to metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of dual acting mmp-2 and mmp-9 inhibiting compounds that exhibit increased potency, metabolic stability and/or reduced toxicity in relation to currently known mmp-2 and mmp-9 inhibitors for the treatment of pain and other diseases.
11/07/13
20130296350
Method of treatment or prophylaxis
The present invention is directed to methods and agents that are useful in the prevention and amelioration of signs and symptoms associated with neuropathic conditions. More particularly, the present invention discloses the use of angiotensin ii receptor 2 (at2 receptor) antagonists for the treatment, prophylaxis, reversal and/or symptomatic relief of neuropathic pain, including mechanical hyperalgesia, thermal or mechanical allodynia, diabetic pain and entrapment pain, in vertebrate animals and particularly in human subjects.
10/31/13
20130287775
Combination therapy for treatment of immune disorders
Methods and compositions are provided for the treatment of immune disorders, such as autoimmune diseases, or cancers, involving combination therapy with agents that inhibit the development or maintenance of th17 cells. Treatment regimens are provided in which an antagonist of a pro-inflammatory cytokine is administered for a time sufficient to alleviate signs and symptoms of an acute phase flare-up of the autoimmune disease, or cancer, and treatment with an antagonist of il-23 is continued for a longer time to prevent recurrence of the acute event.
10/24/13
20130281390
Method for treating dry eye
This invention relates to methods of treating dry eye disease. The methods comprise identifying a patient suffering from dry eye disease, and topically administering to the eyes of the patient an effective amount of azithromycin and an effective amount of a retinoid.
10/17/13
20130274214
Method for treating blepharitis
This invention relates to methods of treating blepharitis. The methods comprise identifying a patient suffering from blepharitis, and topically administering to the eyes of the patient an effective amount of azithromycin and an effective amount of a retinoid.
10/10/13
20130268296
Method and apparatus for identifying, monitoring and treating medical signs and symptoms
A system for identifying and monitoring risk of a plurality of predefined mental health disorders in a single composite score is provided. The system includes a network portal providing access to at least one patient and at least one health care provider; a patient symptom inventory including a grouped, listing of questions corresponding to a plurality of mental symptoms; and a patient assessment progress record including an assessment record for tracking the patient's risk of suffering from the plurality of potential mental conditions over time.
10/10/13
20130267557
Combined use of an alpha-adrenergic receptor antagonist and an anti-muscarinic agent
The combined use of (r)-5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzene-1-sulfonamide (tamsulosin), or its pharmaceutically acceptable salt, and (1s)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid (3r)-quinuclidin-3-yl ester (solifenacin), or its pharmaceutically acceptable salt, for the preparation of a medicament for the improvement of lower urinary tract symptoms associated with benign prostatic hyperplasia (luts/bph) with a substantial storage component is provided.. .
09/05/13
20130231312
Treatment of type ii diabetes and diabetes-associated diseases with safe chemical mitochondrial uncouplers
This application discloses methods for treating, preventing and/or alleviating the symptoms of type ii diabetes and diabetes-related disorders or complications. The invention provides a novel approach to treating and managing disorders and symptoms related to elevated plasma glucose concentrations and insulin resistance, characterized by few side effects and low toxicity.
08/29/13
20130224172
Methods of treating behavioral symptoms of neurological and mental disorders
Disclosed herein are methods of using coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations for treatment of subjects having behavioral disorders, neurological disorders or mental health disorders. Disclosed herein are methods of treating core and non-core symptoms of behavioral disorders, neurological disorders or mental health disorders.
08/08/13
20130204182
Method and apparatus for inserting a rectal suppository
Rectal suppositories are used to administer a predetermined drug dosage to treat a variety of diseases and symptoms in a variety of patient populations. Certain medical conditions, such as digestive disorders, may be more effectively treated when the suppository is placed in a particular location of the patient's anal canal or rectum.
07/25/13
20130190279
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
The present invention refers to the treatment of a patient suffering from rheumatoid arthritis by showing a reduction in signs and symptoms, a major or complete clinical response (remission) or even prevention of structural damages to the joints by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.. .
07/18/13
20130184257
Piperidinyl-substituted lactams as gpr119 modulators
Compounds of formula (i) and pharmaceutically acceptable salts thereof in which x1, x2, l, r3, r4, r5, r7 and n have the meanings given in the specification, are modulators of gpr119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.. .
06/20/13
20130158082
Methods of managing blood sugar levels and compositions related thereto
The disclosure relates to methods of managing blood sugar levels and compositions related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diabetes, insulin resistance, or hyperglycemia comprising administering to a subject diagnosed with, at risk of or exhibiting symptoms of diabetes, insulin resistance, or hyperglycemia a pharmaceutical composition comprising a compound comprising formula i..
06/20/13
20130158009
Piperidinyl-substituted lactams as gpr119 modulators
Compounds of formula (i): and pharmaceutically acceptable salts thereof in which x1, x2, l, r3, r4, r5, r6, r6a, r7, r9, r9a, and n have the meanings given in the specification, are modulators of gpr119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.. .
06/20/13
20130157990
Method of drug detoxification
A method of detoxifying a patient addicted to at least one drug comprises the step of administering a first-medication component to the patient for mitigating drug withdrawal symptoms of the patient. The method further comprises the step of administering an anesthetic component to the patient for putting the patient in a sedated state.
05/23/13
20130131127
Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
Method of using dopamine reuptake inhibitors, e.g., sydnonimine derivatives, for the management of diabetic symptoms and associated complications or conditions, such as hyperglycemia and diabetic neuropathy.. .
05/16/13
20130121992
Molecules and methods for treatment of diabetes
Described are antibodies that specifically recognize and bind the epitope of glutamate decarboxylase (gad65) that is bound by antibody b96.11, and anti-idiotypic antibodies that are capable of competing with gad65 for binding with b96.11 and competitively inhibit such binding. These antibodies can be provided in the form of a pharmaceutical composition and can be used in methods for delaying the onset of type 1 diabetes and for inhibiting insulitis and other diabetic symptoms.
05/02/13
20130109755
Baclofen formulations and methods for making same
Methods for preparing sterilized baclofen solutions include adjusting the ph to below a desired ph, and steam sterilizing the solution with adjusted ph, which results in the solution having the desired ph. Such solutions may also have low concentrations of 4-cpp.
04/25/13
20130102919
Model based control of parkinson's disease
The present invention relates to a novel means to use a fundamental model of the parts of the brain that are dysfunctional in parkinson's disease, and related dynamical diseases of the brain, as part of a feedback control system to modulate the signs and symptoms of disease. Fundamental computational models that embody our knowledge of the anatomy, neurons, and dynamics of the parts of the brain we wish to control, and use those models to reconstruct what is inaccessible to our measurements.
04/04/13
20130085106
Methods and formulations for oxytocin treatment of substance use, psychiatric and other disorders
The invention provides a method of treating a psychiatric or medical disorder in a mammalian subject, the method comprising administering to the subject an effective amount of an oxytocin receptor agonist (e.g., oxytocin). Optionally, the oxytocin receptor agonist is delivered by intranasal administration.
03/28/13
20130080425
Personalized medical treatment provision software
A method for providing information exchange and analysis to a medical knowledge database that collects, organizes, and retrieves clinical experience information sets submitted by a plurality of treatment providers and researchers. The plurality of treatment providers and researchers submit clinical information containing biological sequences, signs and symptoms, and medical assessments to the database.
02/07/13
20130034525
Beta iselets-like cells derived from whole bone marrow
The invention provides for methods of producing pancreatic precursor cells and insulin-producing cells from bone marrow. In various embodiments, bone marrow derived stem cells are differentiated into pancreatic precursor cells and insulin-producing cells.
01/24/13
20130023575
Compositions and methods for the treatment of ocular surface allergies
The disclosure provides ophthalmic compositions, systems and methods for the treatment of ocular surface allergies. More particularly the present invention relates to compositions of bromfenac for the treatment of the signs and symptoms of ocular surface allergies due to seasonal allergies..
01/03/13
20130004428
Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators
This invention relates to diazabicyclononyl oxadiazolyl derivatives, which are found to-be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (cns), the peripheral nervous system (pns), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Symptoms for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Symptoms with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.1524

1966

2 - 1 - 35